The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables

NCT01195805 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Spironolactone
OTHER: Placebo
DRUG: Amiloride

Sponsor

Regional Hospital Holstebro